A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.
NCT01173107 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2010-12-29
Summary
A pilot study for PK/PD parameter of colchicine in Chronic kidney disease patient.
Conditions
Interventions
- DRUG
-
colchicine
colchicine 1T tid
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2010-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Pharmacokinetic Study of an Acute Gout Regimen
NCT01017042 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Exploratory Clinical Study of KUX-1151
NCT02190786 ·Status: COMPLETED ·Phase: PHASE2
-
Allopurinol in Acute Gout
NCT01775098 ·Status: WITHDRAWN ·Phase: NA
-
Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)
NCT03375632 ·Status: COMPLETED ·Phase: PHASE1
-
Uric Acid and the Endothelium in CKD
NCT01228903 ·Status: COMPLETED ·Phase: NA
-
Targeting Inflammation in Acute Coronary Syndrome Using Colchicine
NCT00754819 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Hyperuricaemia on Chronic Renal Disease
NCT03425708 ·Status: UNKNOWN ·Phase: PHASE4
-
Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response
NCT02363725 ·Status: COMPLETED ·Phase: PHASE2
-
Renal PK Study of LC350189
NCT04066712 ·Status: COMPLETED ·Phase: PHASE1
-
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
NCT00978653 ·Status: COMPLETED ·Phase: NA
-
Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome
NCT02153983 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
NCT05745727 ·Status: COMPLETED ·Phase: PHASE1
-
D-0120 Safety and PK/PD Study in China
NCT03923868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189
NCT01361646 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
NCT02287818 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Colchicine Among Patients With COVID-19 Infection
NCT04867226 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients
NCT07064109 ·Status: RECRUITING ·Phase: NA
-
Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
NCT03865407 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Allopurinol on Markers of Mineral and Bone Metabolism
NCT05601271 ·Status: COMPLETED ·Phase: NA
-
A Safety and Tolerability Study of FCN-207 in Healthy Volunteers
NCT04622124 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Colchicine After PCI
NCT06472908 ·Status: RECRUITING ·Phase: PHASE3
-
Phase III Trial of Febuxostat in Korea Gout Patients
NCT00821392 ·Status: COMPLETED ·Phase: PHASE3
-
MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883 ·Status: COMPLETED ·Phase: PHASE3